Most of my clients are small teams with strong science and a clinical program that is about to get expensive.
Therapeutic focus: oncology, immunology and inflammation, and microbiome-based therapies.
I take on the medical leadership work a CMO would own, scoped to what your stage actually needs.
It's one service with one standard of judgment. You decide, at the start of each engagement, whether AI tools may be used on your data.
My preferred tool is Claude, Anthropic's AI model. I use it inside dedicated, sandboxed workspaces set up separately for each client and program. It takes on the labor-intensive parts of the work: literature and landscape synthesis, first drafts of protocols and briefing documents, and consistency checks across documents. You get the same senior review in less time and at lower cost. I verify, edit and sign off every output personally. AI drafts; I decide.
For programs where your policies, partners or the sensitivity of the data rule it out, I work entirely by hand. The scope and quality are the same; timelines and fees reflect the extra hours.
From a single expert session to ongoing leadership. Each one starts with a short scoping call.
| Model | Best for | Commitment |
|---|---|---|
| Fractional CMO | Ongoing medical leadership through a development phase | Set days per month, over several months |
| Project | A defined deliverable: clinical development plan, protocol, regulatory package, advisory board | Fixed scope and timeline |
| Expert intervention | One focused question: a protocol or synopsis review, a regulatory meeting rehearsal, a second opinion on trial design or a safety signal | A few hours to a few days |
| Advisory and diligence | Board support, investor due diligence, scientific advisory boards | Hourly or short retainer |
Every engagement can be delivered with or without AI. Fees are quoted in the proposal.
Network. Over the years I've built a working network of key opinion leaders in the US and Europe in oncology (melanoma, GvHD, colorectal, lung and kidney cancer) and inflammatory bowel disease (ulcerative colitis), along with specialists in AI implementation for the pharmaceutical industry. Clients can draw on it for advisory boards, investigator recruitment and independent second opinions.
Tell me where you are and what's next. I'll reply within two business days to set up a 30-minute call, with no obligation. Or book a slot directly.
Choose a time for a 30-minute introductory call.
Book a 30-minute intro call